Risk factors for colorectal cancer include age, poor diet, obesity, smoking, alcohol, and family history, including hereditary conditions like FAP and HNPCC
The staging of colorectal cancer is done using the TNM staging system, which assesses the size of the tumor, spread to lymph nodes, and presence of metastases
Vogelstein's theory of colonic carcinogenesis explains the multistep model of colorectal cancer development, involving genetic changes from adenoma to carcinoma
Personalized medicine in cancer involves screening, monitoring, molecular diagnostics, and targeted therapy based on individual molecular features of the tumor
Companion diagnostics are tests paired with specific drugs to determine patient response and benefit, such as the Therascreen KRAS PCR Kit for colorectal cancer